AstraZeneca & Daiichi Sankyo’s Enhertu gets US FDA breakthrough therapy designation in US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer ...

US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...

Details concerning the Goserelin acetate medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...

H.R. 875 – Jeremy and Angel Seay and Sergeant Brandon Mendoza Protect Our Communities from DUIs Act of 2025 (June 24, 2025) H.R. 275 – Special Interest Alien Reporting Act of 2025 (June 24, 2025) S.J.

News about the Donald Trump White House administration, including comment and features from the Guardian Hiroshi Nagai, in a post on X, has objected to his artwork being used by the agency to promote ...

To register and receive the Teams link, please email Dr. Christi Camper Moore at [email protected]. To become a successful arts administrator and meet the evolving needs of the field, students need ...